Ling Gu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- Circular RNAs in diseases
- Signaling Pathways in Disease
- RNA modifications and cancer
- Ubiquitin and proteasome pathways
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 6
- Cell death mechanisms and regulation 4
- Renal and related cancers 4
-
- Cancer-related molecular mechanisms research 6
- Cancer, Hypoxia, and Metabolism 6
- Cancer Genomics and Diagnostics 4
- Co-authors
- Stephen A. Murray (4 shared papers)Hongwu Zheng (4 shared papers)Zhi-Xiong Jim Xiao (3 shared papers)Takafumi Uchida (1 shared paper)Xiaoou Tang (1 shared paper)Gerburg M. Wulf (1 shared paper)Xiao Zhen Zhou (1 shared paper)Han You (1 shared paper)
- Journals
- Journal of Experimental & Clinical Cancer Research (3 papers)Cancer Cell International (3 papers)Oncotarget (2 papers)BMC Cancer (2 papers)American Journal of Physiology-Renal Physiology (2 papers)
- Partner nations
- ChinaUnited StatesDenmark
In The Last Decade
Ling Gu
53 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 102
- Cancer Research 485
- Molecular Biology 1.0k
- Oncology 395
- Biological Psychiatry 30
- Immunology 202
Countries citing papers authored by Ling Gu
This map shows the geographic impact of Ling Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Gu more than expected).
Fields of papers citing papers by Ling Gu
This network shows the impact of papers produced by Ling Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Gu. The network helps show where Ling Gu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Gu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 323 | |
| 2 | 2018 | 138 | |
| 3 | 2017 | 70 | |
| 4 | 2017 | 64 | |
| 5 | 2013 | 61 | |
| 6 | 2018 | 57 | |
| 7 | 2010 | 46 | |
| 8 | Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas. | 2000 | 41 |
| 9 | 2017 | 40 | |
| 10 | 2001 | 37 | |
| 11 | 2009 | 36 | |
| 12 | 2008 | 33 | |
| 13 | 2019 | 28 | |
| 14 | 2003 | 28 | |
| 15 | 2011 | 26 | |
| 16 | 2014 | 26 | |
| 17 | 2017 | 24 | |
| 18 | 2010 | 24 | |
| 19 | 2015 | 24 | |
| 20 | Intracellular coexpression of epidermal growth factor receptor, Her-2/neu, and p21ras in human breast cancers: evidence for the existence of distinctive patterns of genetic evolution that are common to tumors from different patients. | 1998 | 23 |
About Ling Gu
Ling Gu is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Pulmonary and Respiratory Medicine, having authored 57 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (6 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Cancer-related molecular mechanisms research (6 papers), Cancer, Hypoxia, and Metabolism (6 papers), Immune Cell Function and Interaction (5 papers), Cancer Genomics and Diagnostics (4 papers), Cell death mechanisms and regulation (4 papers) and Renal and related cancers (4 papers). The work is most often cited by research in Cancer Research (485 citations), Molecular Biology (1.0k citations), Oncology (395 citations), Biological Psychiatry (30 citations) and Immunology (202 citations). Ling Gu has collaborated with scholars based in China, United States and Denmark. Frequent co-authors include Stephen A. Murray, Hongwu Zheng, Zhi-Xiong Jim Xiao, Takafumi Uchida, Xiaoou Tang, Gerburg M. Wulf, Xiao Zhen Zhou, Han You, Kun Ping Lu and Zhigui Ma. Their work appears in journals such as Journal of Experimental & Clinical Cancer Research, Cancer Cell International, Oncotarget, BMC Cancer and American Journal of Physiology-Renal Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.